Fetal Valproate Syndrome with Limb Defects: An Indian Case Report.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28003925)

Published in Case Rep Pediatr on November 24, 2016

Authors

Manisha Goyal1, Ashok Gupta2, Manish Sharma3, Priyanshu Mathur4, Naresh Bansal4

Author Affiliations

1: Rare Disease Clinic, Department of Pediatrics, SMS Medical College, Jaipur, Rajasthan, India.
2: Rare Disease Clinic, Department of Pediatrics, SMS Medical College and Hospitals, Jaipur, Rajasthan, India.
3: Accident Emergency, Department of Pediatrics, SMS Medical College and Hospitals, Jaipur, Rajasthan, India.
4: Department of Pediatrics, SMS Medical College and Hospitals, Jaipur, Rajasthan, India.

Articles cited by this

Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry (2005) 4.86

Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol (2011) 3.93

Comparative safety of antiepileptic drugs during pregnancy. Neurology (2012) 3.32

Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med (2010) 2.94

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study. Lancet Neurol (2013) 2.61

Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group. Seizure (1999) 2.18

Verification of the fetal valproate syndrome phenotype. Am J Med Genet (1988) 1.71

Teratogenicity of valproic acid. J Pediatr (1980) 1.28

Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr (1986) 1.21

Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. J Neurol Neurosurg Psychiatry (2014) 1.15

A mouse model for valproate teratogenicity: parental effects, homeotic transformations, and altered HOX expression. Hum Mol Genet (2000) 1.14

Preaxial ray reduction defects as part of valproic acid embryofetopathy. Prenat Diagn (1993) 1.03

Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR. Am J Med Genet A (2007) 0.93

Prenatal exposure to valproic acid during pregnancy and limb deficiencies: a case-control study. Am J Med Genet (2000) 0.91

Valproate embryopathy: clinical and cognitive profile in 5 siblings. Am J Med Genet A (2005) 0.78

A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect. J Matern Fetal Neonatal Med (2006) 0.78

Articles by these authors

Stickler Syndrome Type 1 with Short Stature and Atypical Ocular Manifestations. Case Rep Pediatr (2016) 0.75